The 'China + 1' strategy (sometimes called 'derisking') is one of the defining global business decisions of this decade. It is not a simple choice between countries — it is a choice between concentration efficiency (keeping everything in one place, where the firm has built capability over 20 years) and strategic resilience (spreading risk across countries that cannot all be hit by the same shock). The answer turns on three factors: (1) the magnitude of the China-specific risks, (2) the firm's capacity to manage multi-country operations, and (3) the cost of duplication versus the cost of a single-country shock.
Arguments FOR the China + 1 diversification
- Reduces single-country risk. A 20-year concentration in China means a single political event (a Taiwan crisis, expanded US sanctions, a sudden Chinese regulatory crackdown) could cripple half the firm's output overnight. Diversifying to two additional countries reduces this exposure dramatically.
- Tariff hedging. US-China tariffs (Section 301 duties of 25%+) make Chinese-made electronics significantly more expensive in the US market. Mexico, with USMCA tariff-free access to the US, sidesteps this entirely. Vietnam has its own tariff arrangements with the US that are more favourable.
- Rising wages in China. Chinese manufacturing wages have risen 5-10x over the past 20 years; Vietnam wages are roughly 50-60% of Chinese levels, Mexico similar. Direct labour cost savings on the diversified portion.
- Customer demand for diversified supply. Major customers (Apple, major automotive brands) are now actively requesting suppliers to demonstrate multi-country resilience. Not diversifying could cost contracts.
- Government incentives. Vietnam offers tax holidays and free-trade-zone benefits to MNCs; Mexico's nearshore proximity to the US is increasingly subsidised. The diversification is partly funded by host governments competing for FDI.
- Multi-country talent access. Vietnam has a growing electronics-engineering talent base from 30+ years of FDI. Mexico has strong automotive and electronics manufacturing capability. The firm gains capability options, not just cost savings.
Arguments AGAINST the China + 1 diversification
- Duplication costs. Two new factories, two new sets of management, two new sets of supplier relationships. Capital cost could easily reach $1-3bn, plus ongoing higher overhead than a single concentrated operation.
- Loss of scale efficiencies. A single Chinese factory of 50,000 workers achieves economies of scale a 25,000-worker factory cannot. Unit costs at the smaller plants will likely be higher than at the consolidated Chinese plant.
- Capability gap. Vietnam and Mexico do not yet match China's depth of supplier ecosystem (component makers, tool makers, logistics). Many specialised components must still be shipped FROM China to the new plants — partly defeating the de-risking goal.
- Quality control complexity. Managing three plants in three countries with different languages, work cultures and regulatory regimes is significantly harder than managing one. Early-year quality risks are real.
- Implementation time. A 50% production shift takes 3-5 years to execute. During the transition, the firm bears both the legacy costs of the China operation and the build costs of the new ones.
- Risk of premature decision. Some of the political risks (Taiwan crisis) may not materialise. If they don't, the firm has paid a high diversification cost for an event that didn't happen.
- Loss of negotiating position with China. Visibly reducing dependence on China may reduce the firm's local political support, potentially worsening conditions for the remaining 50% of operations.
The hidden analytical move — risk is asymmetric
The key insight most analyses miss: the downside of NOT diversifying is much larger than the downside of diversifying.
- Cost of diversifying: maybe 8-15% higher unit costs across the diversified portion, $1-3bn capex over 3-5 years. Quantifiable, manageable, recoverable if conditions change.
- Cost of a major China shock: potentially 50-80% revenue loss in the affected segment, lasting 6-24 months. Tens of billions of $ at risk. Possibly existential.
Even if the probability of a major shock is low (say, 15-20% over 5 years), the expected loss exceeds the cost of diversification by an order of magnitude. This is insurance economics, not just cost optimisation.
Justified judgement and recommendation
The MNC should proceed with the China + 1 diversification, but with three refinements:
- Phase the shift over 5 years, not 2-3. A faster shift risks operational chaos and undermines the very resilience the strategy seeks. Build Vietnam capacity first (year 1-2), Mexico second (year 3-4), shift volume gradually (year 4-5).
- Move different product lines to different countries, not the same products to multiple countries. This means Vietnam handles certain product families end-to-end, Mexico others, China the rest. Each plant becomes the global centre of excellence for its products — preserving scale economies within each plant.
- Maintain key supplier relationships in China even as production moves. Component supply remains diversified across countries; final assembly is what's moved. This captures most of the resilience benefit at lower cost.
Conclusion: do it — but treat it as a 5-year insurance investment in resilience, not a cost-saving exercise.
If the firm waits until a major shock occurs to start diversifying, the cost will be many times higher (panic capex, premium-priced suppliers, retained staff at any price) and the brand damage from supply disruption may be irrecoverable. The right time to buy insurance is before the fire — not during it.
The deeper insight is that for global firms today, supply-chain concentration is a strategic risk in itself, separate from any single political event. A diversified manufacturing footprint is becoming a basic competitive requirement, not an optional luxury — the same way that holding cash reserves and insuring property are basic operating standards.